Government Agencies

A video summary on mpox research and development in the field of diagnostics conducted by the U.S. government.

A video summary of current scientific studies conducted by U.S. government agencies on mpox vaccine effectiveness, safety, equity, and development.

A video summary of current scientific studies conducted by U.S. government agencies on mpox surveillance and population science. 

This video discusses an overview of the new GHSS, the five strategic directions, and the 2025 and 2030 targets. 

The progress countries have made to these goals and what needs to be done to achieve them.   

How community-based organizations and activists can use the GHSS and its targets for advocacy and to hold countries and health systems accountable to their commitments.  

Good practice examples of using the previous GHSS for advocacy and how countries have used GHSS in the planning and implementation of their national programmes.  

The map summarizes state laws and regulations that addresses authorities and protections related to the health departments HIV surveillance data release, which is in response to data requests from courts, prosecutors, and law enforcement agencies. It also reflects laws in Priority Jurisdictions included in Phase I of the federal “Ending the HIV Epidemic: Plan for America” (EHE) initiative, which aims to end the HIV epidemic in the United States by 2030.

The President’s Emergency Plan for AIDS Relief (PEPFAR) is the largest funding source for the HIV response globally, and this webinar was part of the "PEPFAR Watch" webinar series which brings together activists ahead of the Country Operational Plan (COP) planning process to champion community priorities and demands for PEPFAR. 

This report summarizes that the third WHS was held as a predominately virtual event in 2022, with a small in-person hub at the World Health Organization in Geneva, with the theme of “Achieving the elimination of viral hepatitis within evolving health systems”. The programme introduced the new Global Health Sector Strategy (2022-2030) and explored topics across the cascade of care for hepatitis A, B, C, D and E, including barriers such as stigma and discrimination and innovations, like the potential for a functional cure for hepatitis B.

This webinar brings together clinicians, academics, researchers, advocates, professional societies, regulatory agencies and industry representatives to align on best practices to improve treatment for HCV in pregnancy. The TiP-HepC Community of Practice is intended for all stakeholders involved in the care of hepatitis C infection in pregnancy.

The purpose of this toolkit is to help guide jurisdictions in organizing, supporting, and growing viral hepatitis coalitions that are community-oriented and effective in developing, implementing, and evaluating a viral hepatitis strategic plan.

This toolkit is intended to assist health department viral hepatitis programs to assess viral hepatitis testing in laboratories operating in their jurisdictions.